{
    "clinical_study": {
        "@rank": "80440", 
        "acronym": "epidarc", 
        "arm_group": [
            {
                "arm_group_label": "fetal cardiac rhythm abnormally", 
                "arm_group_type": "Other", 
                "description": "patient at term, in spontanous labor with fetal cardiac rythm abnormally which occurs 30 minutes after the epidural analgesia induction"
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Other", 
                "description": "patient at term, spontaneous labor, without any fetal cardiac rhythm abnormalies during the 30 minutes after the epidural analgesia induction"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the investigators study is to demonstrate the association between fetal cardiac\n      rhythm abnormalies after epidural analgesia and the maternal systemic transfer of\n      ropivacaine and/or sufentanil."
        }, 
        "brief_title": "Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Fetal Cardiac Rhythm Abnormalities", 
        "condition_browse": {
            "mesh_term": "Congenital Abnormalities"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years old or more\n\n          -  nulliparous\n\n             _ one fetus\n\n          -  head first\n\n          -  spontaneous labor\n\n          -  epidural analgesia\n\n          -  no fetal cardiac rhythm abnormalies before the epidural analgesia\n\n          -  no active management of labor during 30 minutes after the epidural analgesia\n             induction\n\n          -  at term\n\n          -  signature of the consent form\n\n        Exclusion Criteria:\n\n          -  pathological pregnancy\n\n          -  low maternal blood pressure during the 30 minutes after the epidural analgesia\n\n          -  uterin contraction which last for 5 minutes or more\n\n          -  more than 6 uterin contractions during a 10 minutes period\n\n          -  Ropivacaine contraindication\n\n          -  sufentanil contraindication"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686347", 
            "org_study_id": "2010/146/HP"
        }, 
        "intervention": {
            "arm_group_label": [
                "fetal cardiac rhythm abnormally", 
                "control group"
            ], 
            "intervention_name": "ropivacaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Ropivacaine", 
                "Sufentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "epidural analgesia", 
            "fetal cardiac rythm", 
            "ropivacaine", 
            "sufentanil"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "franck.pizzagali@chu-rouen.fr", 
                "last_name": "pizzagalli franck, widwife", 
                "phone": "0232888990", 
                "phone_ext": "64286"
            }, 
            "facility": {
                "address": {
                    "city": "Rouen", 
                    "country": "France", 
                    "zip": "76000"
                }, 
                "name": "centre hospitalier universitaire de Rouen, Hopital Charles Nicolle"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil", 
        "overall_contact": {
            "email": "franck.pizzagali@chu-rouen.fr", 
            "last_name": "PIZZAGALLI franck, midwife", 
            "phone": "+33232888990", 
            "phone_ext": "64286"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Maternal Plasmatic concentrations of ropivacaine will be measured in mg / liter of maternal blood and the median of each group will be compared by paired Wilcoxon test", 
            "measure": "Plasmatic concentrations compared maternal ropivacaine based on the presence of abnormal fetal heart rate", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686347"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Maternal Plasmatic concentrations of sufentanil will be measured in mg / liter of maternal blood and the median of each group will be compared by paired Wilcoxon test", 
            "measure": "Plasmatic concentrations compared maternal sufentanil based on the presence of abnormal fetal heart rate", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "University Hospital, Rouen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Rouen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}